Sophia Bardehle

Sophia Bardehle is a Principal Scientist in In Vivo Pharmacology at Cerevel Therapeutics since September 2021. Prior to this role, Sophia held positions at Merck as Associate Principal Scientist and Senior Scientist in Neuroimmunology from August 2017 to September 2021, and worked as a Research Scientist and Postdoctoral Research Fellow focusing on neuroinflammation at Gladstone Institutes from November 2013 to July 2017. Educational qualifications include a PhD in Neuroscience from Ludwig-Maximilians-Universität München (2009-2013), a Master of Science in Molecular Medicine from Humboldt-Universität zu Berlin (2006-2008), and a Bachelor of Science in Molecular Biotechnology from Heidelberg University (2003-2006).